2m 2m 2m 2m 2m 2m 2m
Medical Pro REIT (MPT)
NYSE
$2.70$0.00 (0.00%)
Price as of Oct 23, 2026 7:44 PM EDT- $1.6BMarket Cap
- N/A1-Year Change
- REIT - Healthcare FacilitiesIndustry
Medical Pro REIT (MPT)
$2.70$0.00 (0.00%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 972.0M -2.36% | 995.5M +14.19% | 871.8M -43.49% | 1.5B -0.12% | |
Cost of Revenue | 40.0M -46.13% | 74.2M -32.62% | 110.1M -34.25% | 167.4M +65.05% | |
Gross Profit | 932.1M +1.16% | 921.4M +20.96% | 761.7M -44.62% | 1.4B -4.70% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 272.8M -39.87% | 453.7M -26.35% | 616.1M +78.29% | 345.6M +3.53% | |
Total Operating Expenses | 942.6M -8.17% | 1.0B -14.58% | 1.2B +33.79% | 898.2M +2.84% | |
Operating Profit | -237.3M -89.96% | -2.4B +244.25% | -686.8M -171.56% | 959.7M +31.31% | |
Interest Income | 43.6M -10.57% | 48.7M -29.55% | 69.2M -58.39% | 166.2M -1.46% | |
Interest Expense | -510.4M +22.15% | -417.8M +1.62% | -411.2M +14.52% | -359.0M -2.27% | |
Interest Income and Expense and Net | -466.8M +26.47% | -369.1M +7.92% | -342.0M +77.38% | -192.8M -2.97% | |
Total Nonoperating Income and Expense | -266.7M -88.57% | -2.3B +553.77% | -356.9M -213.27% | 315.1M +428.67% | |
Income before Taxes | -237.3M -89.96% | -2.4B +244.25% | -686.8M -171.56% | 959.7M +31.31% | |
Income Taxes | 38.6M -12.43% | 44.1M +133.75% | -130.7M -333.77% | 55.9M -24.41% | |
Extraordinary Items | 11.1M -98.84% | 957.4M +26,474.27% | -3.6M -100.34% | 1.1B +766.10% | |
Net Income | -277.0M -88.51% | -2.4B +333.13% | -556.5M -161.65% | 902.6M +37.59% | |
Net Income from Continuing Operations Applicable to Common | -237.3M -89.96% | -2.4B +244.25% | -686.8M -171.56% | 959.7M +31.31% | |
Basic EPS and Net Income | -0.46 -88.56% | -4.02 +332.26% | -0.93 -162.00% | 1.50 +35.14% | |
Diluted EPS and Net Income | -0.46 -88.56% | -4.02 +332.26% | -0.93 -162.00% | 1.50 +35.14% | |
Basic Weighted Average Shares | 600.9M +0.11% | 600.2M +0.29% | 598.5M -0.02% | 598.6M +1.67% | |
Diluted Weighted Average Shares | 600.9M +0.11% | 600.2M +0.29% | 598.5M -0.05% | 598.8M +1.47% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 540.9M +62.75% | 332.3M +32.93% | 250.0M +6.09% | 235.7M -48.68% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 540.9M +62.75% | 332.3M +32.93% | 250.0M +6.09% | 235.7M -48.68% | |
Total Current Assets | 564.0M +19.65% | 471.4M +2.95% | 457.9M -20.08% | 573.0M +71.82% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | N/A N/A | 115.0M 0.00% | |
Total Long-Term Assets | 564.0M +19.65% | 471.4M +2.95% | 457.9M -20.08% | 573.0M +71.82% | |
Total Assets | 15.0B +4.95% | 14.3B -21.91% | 18.3B -6.88% | 19.7B -4.20% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 600.0M +46.34% | 410.0M -72.67% | 1.5B +61.36% | 929.6M +27.34% | |
Total Current Liabilities | 549.1M +20.89% | 454.2M +10.20% | 412.2M -33.66% | 621.3M +2.23% | |
Total Long-Term Debt | 9.7B +9.60% | 8.8B -12.08% | 10.1B -1.99% | 10.3B -8.99% | |
Total Long-Term Liabilities | 9.7B +9.60% | 8.8B -12.08% | 10.1B -1.99% | 10.3B -8.99% | |
Total Liabilities | 10.4B +9.87% | 9.5B -11.34% | 10.7B -3.55% | 11.1B -8.37% | |
Retained Earnings | -4.1B +13.05% | -3.7B +276.46% | -971.8M -935.71% | 116.3M +232.61% | |
Total Stockholders Equity | 4.6B -4.69% | 4.8B -36.67% | 7.6B -11.19% | 8.6B +1.81% | |
Total Shares Outstanding | 597.0M -0.57% | 600.4M +0.24% | 599.0M +0.25% | 597.5M +0.11% | |
Cash Flow | |||||
Cash from Operating Activities | 230.8M -5.99% | 245.5M -51.47% | 505.8M -31.56% | 739.0M -8.95% | |
Capital Expenditures | 142.1M +34.53% | 105.6M -55.09% | 235.2M -82.36% | 1.3B -75.09% | |
Cash from Investing Activities | -264.7M -120.08% | 1.3B +154.72% | 517.6M +30.68% | 396.1M +110.26% | |
Dividends Paid | 193.3M -39.81% | 321.1M -47.82% | 615.4M -11.90% | 698.5M +8.56% | |
Cash from Financing Activities | 228.1M +115.42% | -1.5B +44.99% | -1.0B -24.00% | -1.3B -145.55% | |
Financials Ratio | |||||
Gross Margin | 95.89% +3.61% | 92.55% +5.92% | 87.37% -1.99% | 89.15% -4.59% | |
Operating Margin | -24.41% -89.72% | -237.48% +201.46% | -78.78% -226.64% | 62.20% +31.46% | |
Return on Assets | -1.89% -87.21% | -14.79% +404.39% | -2.93% -165.25% | 4.49% +27.90% | |
Return on Equity | -5.87% -84.82% | -38.67% +463.80% | -6.86% -164.73% | 10.60% +27.45% | |
Revenue Growth | -2.36% -116.65% | 14.19% +132.64% | -43.49% +36,853.53% | -0.12% -100.50% | |
Current Ratio | 1.03 -1.03% | 1.04 -6.58% | 1.11 +20.47% | 0.92 +68.07% | |
Cash Ratio | 0.99 +34.62% | 0.73 +20.62% | 0.61 +59.93% | 0.38 -49.80% | |
Debt-to-Equity Ratio | 2.24 +16.70% | 1.92 +26.42% | 1.52 +16.28% | 1.30 -8.44% | |
Debt-to-Assets Ratio | 0.69 +5.97% | 0.65 +2.52% | 0.63 +10.92% | 0.57 -2.70% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow